Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FES-Rowing and Zoledronic Acid for Bone Health in SCI
NCT01426555Phase 3Terminated
- Start
- Feb 2011
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
A Phase 3 trial of zoledronic acid in osteoporosis. Started Feb 2011; status: terminated.
02
Drugs
zoledronic acid
03
Conditions
osteoporosis
Beyond the preview
Go deeper on NCT01426555.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01426555.